No Picture
Industry News

Jonathan Lim isn’t ready to say much about his new startup, but he does have $42M for it

Jonathan Lim knows how to build biotechs for a sale. He auctioned off Ignyta ? where he was CEO ? to Roche last February for a tidy $1.7 billion, gaining a 74% premium on his stock. A few months before he also participated in the sale of Bonti to Aller… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Harvard prof Omid Farokhzad heads west, setting up a new Bay Area biotech on a mission to start a revolution in pre-symptomatic disease detection

As a Harvard professor with close ties to MIT?s Bob Langer, Omid Farokhzad has enjoyed a high-profile role in the Boston/Cambridge biotech community, where he?s participated in launching a lineup of startups. And now Farokhzad ? whose accomplishments e… […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Lilly, Incyte’s baricitinib wins fast-track status for hard-to-treat lupus; Synthorx hammers out $150M+ IPO

? Rheumatoid arthritis drug Olumiant?? approved for a narrower-than-expected patient population earlier this year to the dismay of its manufacturer Eli?Lilly $LLY and Incyte $INCY which had blockbuster dreams for the drug?? may be worth its weight in g… […]

No Picture
Industry News

Lilly, Incyte’s baricitinib wins fast-track status for hard-to-treat lupus; Synthorx hammers out $150M+ IPO

? Rheumatoid arthritis drug Olumiant?? approved for a narrower-than-expected patient population earlier this year to the dismay of its manufacturer Eli?Lilly $LLY and Incyte $INCY which had blockbuster dreams for the drug?? may be worth its weight in g… […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

WuXi AppTec cruises toward a steady debut in Hong Kong stock exchange, ending flat on IPO price

Completing a grand plan for a dual listing in Shanghai and Hong Kong in the span of seven months, WuXi AppTec has debuted on the HKEX, ending the day at its original IPO price.
Net proceeds will register at $967 million (HK $7,553 million), the company… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Early Surveillance with L-Dex® Reduces Incidence, Severity & Cost of Breast Cancer-Related Lymphedema, ImpediMed Reports Publication in American Cancer Society Journal

BRISBANE, Australia & CARLSBAD, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Lymphedema?src=hash" target="_blank"gt;#Lymphedemalt;/agt;–L-Dex Reduces Incidence, Severity & Cost of Breast Cancer-Related Ly… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Apexian Pharmaceuticals Presents Findings at ASH Meeting Demonstrating APX3330 Impact on Inflammation and Leukemia?in Preclinical Models

INDIANAPOLIS–(BUSINESS WIRE)–Apexian Pharmaceuticals is shedding light on the question of how pre-leukemic cells transform into full-blown leukemia. Genetic mutations by themselves are rarely enough to flip the switch. Inflammation also plays a role…. […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks